{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:01:00Z","timestamp":1787896860192,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,10]]},"DOI":"10.7759\/cureus.80335","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T11:46:21Z","timestamp":1741607181000},"source":"Crossref","is-referenced-by-count":2,"title":["Machine Learning Algorithms Introduce Evoked Potentials As Alternative Biomarkers for the Expanded Disability Status Scale Prognosis of Multiple Sclerosis Patients"],"prefix":"10.7759","author":[{"given":"Dionysia C","family":"Chrysanthakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Koutsojannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001136","article-title":"Epidemiology and pathophysiology of multiple sclerosis","volume":"28","author":"Ward M","year":"2022","unstructured":"Ward M, Goldman MD. Epidemiology and pathophysiology of multiple sclerosis. Continuum (Minneap Minn). 2022, 28:988-1005. 10.1212\/CON.0000000000001136","journal-title":"Continuum (Minneap Minn)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102512","article-title":"Clinical outcome measures in multiple sclerosis: a review","volume":"19","author":"Inojosa H","year":"2020","unstructured":"Inojosa H, Schriefer D, Ziemssen T. Clinical outcome measures in multiple sclerosis: a review. Autoimmun Rev. 2020, 19:102512. 10.1016\/j.autrev.2020.102512","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.12.006","article-title":"Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis","volume":"20","author":"Wang G","year":"2018","unstructured":"Wang G, Marrie RA, Fox RJ, Tyry T, Cofield SS, Cutter GR, Salter A. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis. Mult Scler Relat Disord. 2018, 20:16-21. 10.1016\/j.msard.2017.12.006","journal-title":"Mult Scler Relat Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1039\/9781788016070-00001","article-title":"Multiple Sclerosis: Epidemiology, Genetics, Symptoms, and Unmet Needs","author":"Moreno-Torres I","year":"2019","unstructured":"Moreno-Torres I, Sab\u00edn-Mu\u00f1oz J, Garc\u00eda-Merino A. Multiple Sclerosis: Epidemiology, Genetics, Symptoms, and Unmet Needs. Emerging Drugs and Targets for Multiple Sclerosis. Martinez A (ed): The Royal Society of Chemistry, 2019.  1-32. 10.1039\/9781788016070-00001"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190460","article-title":"Pathogenic T cell cytokines in multiple sclerosis","volume":"217","author":"Wagner CA","year":"2020","unstructured":"Wagner CA, Roqu\u00e9 PJ, Goverman JM. Pathogenic T cell cytokines in multiple sclerosis. J Exp Med. 2020, 217:e20190460. 10.1084\/jem.20190460","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou CA","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015, 15:545-58. 10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak RP","year":"2012","unstructured":"Lisak RP, Benjamins JA, Nedelkoska L, et al.. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. J Neuroimmunol. 2012, 246:85-95. 10.1016\/j.jneuroim.2012.02.015","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention","volume":"141","author":"van Langelaar J","year":"2018","unstructured":"van Langelaar J, van der Vuurst de Vries RM, Janssen M, et al.. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain. 2018, 141:1334-49. 10.1093\/brain\/awy069","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.06.023","article-title":"Microglia in multiple sclerosis: protectors turn destroyers","volume":"110","author":"Yong VW","year":"2022","unstructured":"Yong VW. Microglia in multiple sclerosis: protectors turn destroyers. Neuron. 2022, 110:3534-48. 10.1016\/j.neuron.2022.06.023","journal-title":"Neuron"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The","volume":"17","author":"Thompson AJ","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The. Lancet Neurol. 2018, 17:10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516638941","article-title":"The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis","volume":"23","author":"Cadavid D","year":"2017","unstructured":"Cadavid D, Cohen JA, Freedman MS, et al.. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Mult Scler. 2017, 23:94-105. 10.1177\/1352458516638941","journal-title":"Mult Scler"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth YC","year":"2013","unstructured":"Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013, 13:37. 10.1186\/1471-2377-13-37","journal-title":"BMC Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.34.10.1368","article-title":"A neurologic rating scale (NRS) for use in multiple sclerosis","volume":"34","author":"Sipe JC","year":"1984","unstructured":"Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 1984, 34:1368-72. 10.1212\/wnl.34.10.1368","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1179\/1743132810Y.0000000017","article-title":"Functional system scores provide a window into disease activity occurring during a multiple sclerosis treatment trial","volume":"33","author":"Scott TF","year":"2011","unstructured":"Scott TF, You X, Foulds P. Functional system scores provide a window into disease activity occurring during a multiple sclerosis treatment trial. Neurol Res. 2011, 33:549-52. 10.1179\/1743132810Y.0000000017","journal-title":"Neurol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/20552173221105642","article-title":"Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?","volume":"8","author":"Bharadia T","year":"2022","unstructured":"Bharadia T, Vandercappellen J, Chitnis T, et al.. Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?. Mult Scler J Exp Transl Clin. 2022, 8:20552173221105642. 10.1177\/20552173221105642","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520925369","article-title":"Aggressive multiple sclerosis (1): towards a definition of the phenotype","volume":"26","author":"Iacobaeus E","year":"2020","unstructured":"Iacobaeus E, Arrambide G, Amato MP, et al.. Aggressive multiple sclerosis (1): towards a definition of the phenotype. Mult Scler. 2020, 26:1352458520925369. 10.1177\/1352458520925369","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115877","article-title":"Current and future biomarkers in multiple sclerosis","volume":"23","author":"Yang J","year":"2022","unstructured":"Yang J, Hamade M, Wu Q, Wang Q, Axtell R, Giri S, Mao-Draayer Y. Current and future biomarkers in multiple sclerosis. Int J Mol Sci. 2022, 23:5877. 10.3390\/ijms23115877","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S98936","article-title":"Biomarkers of multiple sclerosis: current findings","volume":"7","author":"Harris VK","year":"2017","unstructured":"Harris VK, Tuddenham JF, Sadiq SA. Biomarkers of multiple sclerosis: current findings. Degener Neurol Neuromuscul Dis. 2017, 7:19-29. 10.2147\/DNND.S98936","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh J","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018, 31:752-9. 10.1097\/WCO.0000000000000622","journal-title":"Curr Opin Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185621","article-title":"Multiple sclerosis and demyelinating disorders: past, present, and future","volume":"13","author":"Bakirtzis C","year":"2024","unstructured":"Bakirtzis C, Evangelopoulos ME, Grigoriadis N. Multiple sclerosis and demyelinating disorders: past, present, and future. J Clin Med. 2024, 13:5621. 10.3390\/jcm13185621","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000725","article-title":"Multiple sclerosis risk factors and pathogenesis","volume":"25","author":"Nourbakhsh B","year":"2019","unstructured":"Nourbakhsh B, Mowry EM. Multiple sclerosis risk factors and pathogenesis. Continuum (Minneap Minn). 2019, 25:596-610. 10.1212\/CON.0000000000000725","journal-title":"Continuum (Minneap Minn)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu15132978","article-title":"The role of vitamin D in neuroprotection in multiple sclerosis: an update","volume":"15","author":"Sangha A","year":"2023","unstructured":"Sangha A, Quon M, Pfeffer G, Orton SM. The role of vitamin D in neuroprotection in multiple sclerosis: an update. Nutrients. 2023, 15:2978. 10.3390\/nu15132978","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki M","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA. Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore). 2024, 103:e37297. 10.1097\/MD.0000000000037297","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520915629","article-title":"Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course","volume":"26","author":"Kalb R","year":"2020","unstructured":"Kalb R, Brown TR, Coote S, et al.. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. 2020, 26:1459-69. 10.1177\/1352458520915629","journal-title":"Mult Scler"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","volume":"90","author":"McKay KA","year":"2018","unstructured":"McKay KA, Tremlett H, Fisk JD, et al.. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018, 90:e1316-23. 10.1212\/WNL.0000000000005302","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000970","article-title":"Effectiveness of physiotherapy interventions on spasticity in people with multiple sclerosis: a systematic review and meta-analysis","volume":"97","author":"Etoom M","year":"2018","unstructured":"Etoom M, Khraiwesh Y, Lena F, Hawamdeh M, Hawamdeh Z, Centonze D, Foti C. Effectiveness of physiotherapy interventions on spasticity in people with multiple sclerosis: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2018, 97:793-807. 10.1097\/PHM.0000000000000970","journal-title":"Am J Phys Med Rehabil"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104424","article-title":"Mobility and balance rehabilitation in multiple sclerosis: a systematic review and dose-response meta-analysis","volume":"69","author":"Corrini C","year":"2023","unstructured":"Corrini C, Gervasoni E, Perini G, et al.. Mobility and balance rehabilitation in multiple sclerosis: a systematic review and dose-response meta-analysis. Mult Scler Relat Disord. 2023, 69:104424. 10.1016\/j.msard.2022.104424","journal-title":"Mult Scler Relat Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102143","article-title":"Exercise improves neurotrophins in multiple sclerosis independent of disability status","volume":"43","author":"Banitalebi E","year":"2020","unstructured":"Banitalebi E, Ghahfarrokhi MM, Negaresh R, Kazemi A, Faramarzi M, Motl RW, Zimmer P. Exercise improves neurotrophins in multiple sclerosis independent of disability status. Mult Scler Relat Disord. 2020, 43:102143. 10.1016\/j.msard.2020.102143","journal-title":"Mult Scler Relat Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520924595","article-title":"Aggressive multiple sclerosis (2): treatment","volume":"26","author":"Arrambide G","year":"2020","unstructured":"Arrambide G, Iacobaeus E, Amato MP, et al.. Aggressive multiple sclerosis (2): treatment. Mult Scler. 2020, 26:1352458520924595. 10.1177\/1352458520924595","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin FD","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, et al.. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014, 83:278-86. 10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2013.07.001","article-title":"Evoked potentials in multiple sclerosis","volume":"24","author":"Kraft GH","year":"2013","unstructured":"Kraft GH. Evoked potentials in multiple sclerosis. Phys Med Rehabil Clin N Am. 2013, 24:717-20. 10.1016\/j.pmr.2013.07.001","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000723","article-title":"Multimodal evoked potentials as candidate prognostic and response biomarkers in clinical trials of multiple sclerosis","volume":"38","author":"Hardmeier M","year":"2021","unstructured":"Hardmeier M, Fuhr P. Multimodal evoked potentials as candidate prognostic and response biomarkers in clinical trials of multiple sclerosis. J Clin Neurophysiol. 2021, 38:171-80. 10.1097\/WNP.0000000000000723","journal-title":"J Clin Neurophysiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/s23010497","article-title":"Assessment of motor evoked potentials in multiple sclerosis","volume":"23","author":"\u0160oda J","year":"2023","unstructured":"\u0160oda J, Pavelin S, Vujovi\u0107 I, Rogi\u0107 Vidakovi\u0107 M. Assessment of motor evoked potentials in multiple sclerosis. Sensors (Basel). 2023, 23:497. 10.3390\/s23010497","journal-title":"Sensors (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000734","article-title":"The use of motor-evoked potentials in clinical trials in multiple sclerosis","volume":"38","author":"Fern\u00e1ndez V","year":"2021","unstructured":"Fern\u00e1ndez V. The use of motor-evoked potentials in clinical trials in multiple sclerosis. J Clin Neurophysiol. 2021, 38:166-70. 10.1097\/WNP.0000000000000734","journal-title":"J Clin Neurophysiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.82.10_supplement.p4.193","article-title":"A multi-modal neurophysiological evaluation of primary progressive multiple sclerosis - a cross sectional &\u202flongitudinal cohort analysis (P4.193)","volume":"82","author":"Canham L","year":"2014","unstructured":"Canham L, Cottrell D, Kane N, Witherick J, Blake K, Walsh P. A multi-modal neurophysiological evaluation of primary progressive multiple sclerosis - a cross sectional &\u202flongitudinal cohort analysis (P4.193). Neurology. 2014, 82:10.1212\/wnl.82.10_supplement.p4.193","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00735","article-title":"Validation of quantitative scores derived from motor evoked potentials in the assessment of primary progressive multiple sclerosis: a longitudinal study","volume":"11","author":"Hardmeier M","year":"2020","unstructured":"Hardmeier M, Schindler C, Kuhle J, Fuhr P. Validation of quantitative scores derived from motor evoked potentials in the assessment of primary progressive multiple sclerosis: a longitudinal study. Front Neurol. 2020, 11:735. 10.3389\/fneur.2020.00735","journal-title":"Front Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrmge.2020.05.010","article-title":"Application of artificial intelligence to rock mechanics: an overview","volume":"13","author":"Lawal AI","year":"2021","unstructured":"Lawal AI, Kwon S. Application of artificial intelligence to rock mechanics: an overview. J Rock Mech Geotech Eng. 2021, 13:10.1016\/j.jrmge.2020.05.010","journal-title":"J Rock Mech Geotech Eng"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1109\/ISCC.2017.8024530","article-title":"A Comprehensive Investigation and Comparison of Machine Learning Techniques in the Domain of Heart Disease","author":"Pouriyeh S","year":"2017","unstructured":"Pouriyeh S, Vahid S, Sannino G, Pietro GD, Arabnia HR, Gutierrez JB. A Comprehensive Investigation and Comparison of Machine Learning Techniques in the Domain of Heart Disease. International Symposium on Computers and Communications. Heraklion, Greece; 2017. 204-207. 10.1109\/ISCC.2017.8024530"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2021.11.008","article-title":"Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: a systematic review","volume":"19","author":"Anderson AW","year":"2022","unstructured":"Anderson AW, Marinovich ML, Houssami N, et al.. Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: a systematic review. J Am Coll Radiol. 2022, 19:259-73. 10.1016\/j.jacr.2021.11.008","journal-title":"J Am Coll Radiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.007","article-title":"Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges","volume":"471","author":"Huang S","year":"2020","unstructured":"Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges. Cancer Lett. 2020, 471:61-71. 10.1016\/j.canlet.2019.12.007","journal-title":"Cancer Lett"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102843","article-title":"Conversion predictors of clinically isolated syndrome to multiple sclerosis in Mexican patients: a prospective study","volume":"54","author":"Chavarria V","year":"2023","unstructured":"Chavarria V, Espinosa-Ram\u00edrez G, Sotelo J, et al.. Conversion predictors of clinically isolated syndrome to multiple sclerosis in Mexican patients: a prospective study. Arch Med Res. 2023, 54:102843. 10.1016\/j.arcmed.2023.102843","journal-title":"Arch Med Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1109\/ANZIIS.1994.396988","article-title":"Weka: A Machine Learning Workbench","author":"Holmes G","year":"1994","unstructured":"Holmes G, Donkin A, Witten I. Weka: A Machine Learning Workbench. Proceedings of ANZIIS '94 - Australian New Zealand Intelligent Information Systems Conference. QLD, Australia; 1994. 357-61. 10.1109\/ANZIIS.1994.396988"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.25046\/aj050315","article-title":"University students result analysis and prediction system by decision tree algorithm","volume":"5","author":"Hoque I","year":"2020","unstructured":"Hoque I, Azad AK, Tuhin MAH, Salehin ZU. University students result analysis and prediction system by decision tree algorithm. Adv Sci Technol Eng Syst. 2020, 5:115-22. 10.25046\/aj050315","journal-title":"Adv Sci Technol Eng Syst"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2008.03.002","article-title":"An artificial multilayer perceptron neural network for diagnosis of proximal dental caries","volume":"106","author":"Devito KL","year":"2008","unstructured":"Devito KL, de Souza Barbosa F, Felippe Filho WN. An artificial multilayer perceptron neural network for diagnosis of proximal dental caries. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008, 106:879-84. 10.1016\/j.tripleo.2008.03.002","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-02013-4","article-title":"A Bayesian latent class extension of naive Bayesian classifier and its application to the classification of gastric cancer patients","volume":"23","author":"Gohari K","year":"2023","unstructured":"Gohari K, Kazemnejad A, Mohammadi M, Eskandari F, Saberi S, Esmaieli M, Sheidaei A. A Bayesian latent class extension of naive Bayesian classifier and its application to the classification of gastric cancer patients. BMC Med Res Methodol. 2023, 23:190. 10.1186\/s12874-023-02013-4","journal-title":"BMC Med Res Methodol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2011.01762.x","article-title":"A na\u00efve Bayes classifier for planning transfusion requirements in heart surgery","volume":"19","author":"Cevenini G","year":"2013","unstructured":"Cevenini G, Barbini E, Massai MR, Barbini P. A na\u00efve Bayes classifier for planning transfusion requirements in heart surgery. J Eval Clin Pract. 2013, 19:25-9. 10.1111\/j.1365-2753.2011.01762.x","journal-title":"J Eval Clin Pract"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1980.tb03029.x","article-title":"The value of brain stem auditory, visual and somatosensory evoked potentials and blink reflexes in the diagnosis of multiple sclerosis","volume":"62","author":"Kjaer M","year":"1980","unstructured":"Kjaer M. The value of brain stem auditory, visual and somatosensory evoked potentials and blink reflexes in the diagnosis of multiple sclerosis. Acta Neurol Scand. 1980, 62:220-36. 10.1111\/j.1600-0404.1980.tb03029.x","journal-title":"Acta Neurol Scand"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11407-1","article-title":"Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis","volume":"270","author":"Wuschek A","year":"2023","unstructured":"Wuschek A, Bussas M, El Husseini M, et al.. Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis. J Neurol. 2023, 270:824-30. 10.1007\/s00415-022-11407-1","journal-title":"J Neurol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s100720070079","article-title":"EDSS correlated analysis of median nerve somatosensory evoked potentials in multiple sclerosis","volume":"21","author":"Koehler J","year":"2000","unstructured":"Koehler J, Faldum A, Hopf HC. EDSS correlated analysis of median nerve somatosensory evoked potentials in multiple sclerosis. Neurol Sci. 2000, 21:217-21. 10.1007\/s100720070079","journal-title":"Neurol Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-80","article-title":"Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?","volume":"12","author":"Margaritella N","year":"2012","unstructured":"Margaritella N, Mendozzi L, Garegnani M, Nemni R, Colicino E, Gilardi E, Pugnetti L. Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?. BMC Neurol. 2012, 12:80. 10.1186\/1471-2377-12-80","journal-title":"BMC Neurol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514525867","article-title":"Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years","volume":"20","author":"Schlaeger R","year":"2014","unstructured":"Schlaeger R, Schindler C, Grize L, Dellas S, Radue EW, Kappos L, Fuhr P. Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years. Mult Scler. 2014, 20:1348-54. 10.1177\/1352458514525867","journal-title":"Mult Scler"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2015.03.012","article-title":"Evoked potentials and disability in multiple sclerosis: a different perspective to a neglected method","volume":"133","author":"Kiylioglu N","year":"2015","unstructured":"Kiylioglu N, Parlaz AU, Akyildiz UO, Tataroglu C. Evoked potentials and disability in multiple sclerosis: a different perspective to a neglected method. Clin Neurol Neurosurg. 2015, 133:11-7. 10.1016\/j.clineuro.2015.03.012","journal-title":"Clin Neurol Neurosurg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511416836","article-title":"Prediction of long-term disability in multiple sclerosis","volume":"18","author":"Schlaeger R","year":"2012","unstructured":"Schlaeger R, D'Souza M, Schindler C, et al.. Prediction of long-term disability in multiple sclerosis. Mult Scler. 2012, 18:31-8. 10.1177\/1352458511416836","journal-title":"Mult Scler"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341963-machine-learning-algorithms-introduce-evoked-potentials-as-alternative-biomarkers-for-the-expanded-disability-status-scale-prognosis-of-multiple-sclerosis-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T11:46:23Z","timestamp":1741607183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341963-machine-learning-algorithms-introduce-evoked-potentials-as-alternative-biomarkers-for-the-expanded-disability-status-scale-prognosis-of-multiple-sclerosis-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.80335","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}